Literature DB >> 24776550

Evidence-based medicine: Blepharoplasty.

Brian C Drolet1, Patrick K Sullivan.   

Abstract

LEARNING
OBJECTIVES: After studying this article, the participant should be able to: (1) Identify the essential preoperative considerations for patients undergoing blepharoplasty. (2) Describe upper and lower eyelid anatomy and the relevance to blepharoplasty techniques. (3) Discuss a standard approach to upper and lower lid blepharoplasty, beginning with preoperative assessment, planning, and marking. 4. Describe the major considerations in periorbital rejuvenation and the critical steps taken during blepharoplasty to create aesthetic improvements.
SUMMARY: Blepharoplasty is one of the most common aesthetic procedures performed in the United States. Significant improvements in facial aesthetics can be made with a relatively short operation that can be performed under intravenous sedation or entirely with local anesthesia. Upper blepharoplasty focuses primarily on removal of excess skin and aesthetic placement of the supratarsal crease, along with filling and contouring of a deep upper orbital sulcus with injections when necessary. Lower blepharoplasty addresses the orbitomalar sulcus (lid-cheek junction and tear-trough abnormalities) and pseudoherniation of periorbital fat, and is based on selective removal and repositioning of fat. Upper blepharoplasty generally does not require fat removal. In addition, lower blepharoplasty involves releasing deep structures, whereas upper blepharoplasty is generally more superficial. In general, the upper lid should be approached transcutaneously, whereas lower blepharoplasty can be safely performed through a transconjunctival or a transcutaneous incision. Complications of upper blepharoplasty are uncommon with more current techniques, but lower lid blepharoplasty has potentially disastrous complications. Blepharoplasty can significantly enhance periorbital and midface aesthetics by improving the tired appearance of even young patients, and is an important tool for facial rejuvenation.

Entities:  

Mesh:

Year:  2014        PMID: 24776550     DOI: 10.1097/PRS.0000000000000087

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Aseptic surgical preparation for upper eyelid blepharoplasty via full-face octenidine antiseptic without antibiotic medication shows effective prophylaxis against post-surgical wound infection.

Authors:  Johannes Matiasek; Philip Kienzl; Gerlinde R Otti; Bela R Turk; Gabriel Djedovic; Ulrich M Rieger
Journal:  Int Wound J       Date:  2017-10-23       Impact factor: 3.315

2.  Continuous Wave Fractional CO2 Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation.

Authors:  Melissa Morrison Toyos
Journal:  Photomed Laser Surg       Date:  2017-01-12       Impact factor: 2.796

3.  How to Make Your Life Easier: Blepharoplasty Markings with Microsurgical Clamps.

Authors:  Vittorio Ramella; Chiara Stocco; Federico Facchin; Luigi Troisi; Giovanni Papa; Zoran Marij Arnez
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-08

4.  Periorbital Aesthetic Surgery: A Simple Algorithm for the Optimal Youthful Appearance.

Authors:  Ersin Akşam; Berrak Karatan
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

5.  Evaluation of Fat Excision versus Sparing in Lower Blepharoplasty Using Orbital Gray Scale Analysis.

Authors:  Adnan Gamal Etman; Mohamed Samir Badawy; Hany Saad Setta; Amr Magdy; Ahmed El-Badawy
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-09-30

6.  Which Tissue Should Be Removed in Upper Blepharoplasty? Analysis and Evaluation of Satisfaction.

Authors:  Ali A Saalabian; Paul Liebmann; Maria Deutinger
Journal:  World J Plast Surg       Date:  2017-09

7.  Effect of upper eyelid blepharoplasty on corneal biomechanical, topographic and tomographic parameters 4 weeks after surgery.

Authors:  Falk Sommer; Elisa Untch; Eberhard Spoerl; Robert Herber; Lutz E Pillunat; Naim Terai
Journal:  Int Ophthalmol       Date:  2021-09-03       Impact factor: 2.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.